Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MacroGenics Inc MGNX

Healthcare Biotechnology
MacroGenics, Inc. is a biopharmaceutical company focused on developing and commercializing monoclonal antibody-based therapeutics for the treatment of cancer. It generates its pipeline of product candidates primarily from its suite of antibody-based technology platforms, which have applicability across broad therapeutic domains. It is developing product candidates that target various tumor... see more

Recent & Breaking News (NDAQ:MGNX)

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 24, 2024 in MacroGenics, Inc. Lawsuit - MGNX

Accesswire September 2, 2024

MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit

PR Newswire September 2, 2024

September 24, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against MGNX

Accesswire September 2, 2024

Investors who Lost Money on MacroGenics, Inc. (MGNX) Should Contact Levi & Korsinsky About Pending Class Action - MGNX

Accesswire September 2, 2024

MacroGenics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 24, 2024 to Discuss Your Rights - MGNX

Accesswire September 2, 2024

MacroGenics Inc Is Being Sued For Acting Wrongfully And Investors With Losses Are Urged To Contact The Schall Law Firm

Accesswire September 2, 2024

MGNX LAWSUIT ALERT: Levi & Korsinsky Notifies MacroGenics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

Accesswire September 1, 2024

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages MacroGenics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MGNX

Newsfile September 1, 2024

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of MacroGenics, Inc.(MGNX) Shareholders

Accesswire September 1, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against MacroGenics, Inc. - MGNX

Accesswire September 1, 2024

MacroGenics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before September 24, 2024 to Discuss Your Rights - MGNX

Accesswire September 1, 2024

The Schall Law Firm Wants The Public To Participate In A Securities Fraud Case Against MacroGenics Inc.

Accesswire September 1, 2024

Kessler Topaz Meltzer & Check, LLP Notifies MacroGenics, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit

PR Newswire September 1, 2024

MacroGenics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 24, 2024 to Discuss Your Rights - MGNX

Accesswire September 1, 2024

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics

Newsfile September 1, 2024

Lost Money on MacroGenics, Inc.(MGNX)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

Accesswire August 31, 2024

MGNX Equity Alert: Kessler Topaz Meltzer & Check, LLP Alerts Shareholders of Securities Fraud Class Action Lawsuit Filed against MacroGenics, Inc.

Accesswire August 31, 2024

MacroGenics Inc Is Being Sued For Potentially Illegal Actions And Investors With Losses Should Contact The Schall Law Firm

Accesswire August 31, 2024

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics

PR Newswire August 31, 2024

ROSEN, A LEADING LAW FIRM, Encourages MacroGenics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MGNX

Newsfile August 30, 2024